ArticleScientific reports2025
Interpretable multi-model deep learning framework for automated four-class diagnosis of ocular toxoplasmosis using fundus imaging.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- FRDNAC: A Future-Ready DNA Cryptography Paradigm for Secure Cloud Data Transmission Using Deep Learning-Enhanced Key Generation.Interdisciplinary sciences, computational life sciences · 2026Article
- A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy for Human Toxoplasmosis: Performance, Populations, and Validation Gaps.Medical devices (Auckland, N.Z.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular toxoplasmosis (OT) remains a leading cause of posterior uveitis worldwide, where accurate differentiation between Active, Inactive, Mixed, and Healthy retinal states is critical for appropriate management. Existing deep learning studies primarily address binary classification, offering limited diagnostic granularity and interpretability. This study introduces a comprehensive and interpretable multi-model deep learning framework designed for four-class classification of OT using retinal fundus images. The framework integrates convolutional neural networks (CNNs), Vision Transformers (ViT), YOLOv8, YOLOv11, and an ensemble model, optimized through systematic hyperparameter tuning and dataset balancing. Performance was evaluated on multiple dataset variants and externally validated on independent datasets. Interpretability was assessed using SHAP and EigenCAM to ensure transparency and clinical coherence. This framework achieved a 98% classification accuracy and a Matthews Correlation Coefficient (MCC) of 0.885, demonstrating balanced and robust performance across all categories. The YOLOv11 model yielded the highest accuracy, effectively localizing lesion rich regions through anchor-free detection. The Vision Transformer provided superior contextual understanding, while green-channel preprocessing and class balancing significantly enhanced lesion contrast and model generalization. SHAP and EigenCAM analyses confirmed that predictions corresponded to clinically relevant retinal structures, supporting model transparency and interpretability. Inference benchmarking showed the accelerations of Graphics Processing Unit (GPU) and Central Processing Unit (CPU) for real-time clinical deployment, with YOLO v11 achieving a latency of 2.8ms and 65ms respectively. This framework establishes a new benchmark for interpretable AI in ocular toxoplasmosis classification. Its integration of multi-architecture design, spectral preprocessing, and explainable visual reasoning enables accurate, transparent, and generalizable diagnosis. These findings highlight this study's potential for real-world integration into teleophthalmology, screening programs, and clinical decision-support systems, paving the way for trustworthy and scalable retinal AI solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.